Skip to main content

Table 5 Validation of the novel stratification rule

From: Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study

APACHEII score

suPAR

Survivors, Number (%)

Non-survivors, Number (%)

P value

OR (95 % CI)

<15

<10.82

71(98.61 %)

1(1.39 %)

<0.001**

4.72 (3.36–5.81)

 

≥10.82

24(88.89 %)

3(11.11 %)

  

≥15

<10.82

13(72.22 %)

5(27.78 %)

<0.001**

2.04 (1.85–3.50)

 

≥10.82

9(45.00 %)

11(55.00 %)

  
  1. Abbreviations: APACHE II Acute Physiology and Chronic Health Evaluation II, suPAR soluble urokinase plasminogen activator receptor, OR odds ratio, CI confidence interval
  2. The OR indicates the risk of obtaining unfavorable outcome
  3. Significant differences are marked by **(P < 0.01)
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us